Literature DB >> 25279574

Myostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia?

Mathis Grossmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25279574     DOI： 10.1210/jc.2014-3290

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

1.  Impact of Preoperative Skeletal Muscle Quality Measurement on Long-Term Survival After Curative Gastrectomy for Locally Advanced Gastric Cancer.

Authors:  Yuhei Waki; Tomoyuki Irino; Rie Makuuchi; Akifumi Notsu; Satoshi Kamiya; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

Review 2.  Selecting Potential Pharmacological Interventions in Sarcopenia.

Authors:  Amanda J Kilsby; Avan A Sayer; Miles D Witham
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

3.  Assessment of sarcopenia as a predictor of poor overall survival for advanced non-small-cell lung cancer patients receiving salvage anti-PD-1 immunotherapy.

Authors:  Yixing Wang; Ping Chen; Jinsheng Huang; Minghui Liu; Dingsheng Peng; Zichun Li; Tao Chen; Shaodong Hong; Yixin Zhou
Journal:  Ann Transl Med       Date:  2021-12

4.  Effects of an ActRIIB.Fc Ligand Trap on Cardiac Function in Simian Immunodeficiency Virus-Infected Male Rhesus Macaques.

Authors:  Wen Guo; Karol M Pencina; Thiago Gagliano-Jucá; Ravi Jasuja; Nancy Morris; Karyn E O'Connell; Susan Westmoreland; Shalender Bhasin
Journal:  J Endocr Soc       Date:  2018-05-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.